Cargando…

Differences in Executive Function Among Patients With Schizophrenia, Their Unaffected First-Degree Relatives, and Healthy Participants

BACKGROUND: Patients with schizophrenia (SCZ) display impaired executive functions compared with healthy controls (HCs). Furthermore, unaffected first-degree relatives (FRs) of patients with SCZ independently perform worse executive functions than do HCs. However, few studies have investigated the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataoka, Yuzuru, Shimada, Takamitsu, Koide, Yoko, Okubo, Hiroaki, Uehara, Takashi, Shioiri, Toshiki, Kawasaki, Yasuhiro, Ohi, Kazutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745249/
https://www.ncbi.nlm.nih.gov/pubmed/32692837
http://dx.doi.org/10.1093/ijnp/pyaa052
_version_ 1783624575763873792
author Kataoka, Yuzuru
Shimada, Takamitsu
Koide, Yoko
Okubo, Hiroaki
Uehara, Takashi
Shioiri, Toshiki
Kawasaki, Yasuhiro
Ohi, Kazutaka
author_facet Kataoka, Yuzuru
Shimada, Takamitsu
Koide, Yoko
Okubo, Hiroaki
Uehara, Takashi
Shioiri, Toshiki
Kawasaki, Yasuhiro
Ohi, Kazutaka
author_sort Kataoka, Yuzuru
collection PubMed
description BACKGROUND: Patients with schizophrenia (SCZ) display impaired executive functions compared with healthy controls (HCs). Furthermore, unaffected first-degree relatives (FRs) of patients with SCZ independently perform worse executive functions than do HCs. However, few studies have investigated the differences in executive functions assessed among patients with SCZ, FRs, and HCs, and the findings are inconsistent. METHODS: We investigated diagnostic differences in executive functions, namely (1) numbers of categories achieved (CA), (2) total errors (TE), and (3) percentage of perseverative errors of Nelson types (%PEN), using the Wisconsin card sorting test among patients with SCZ (n = 116), unaffected FRs (n = 62), and HCs (n = 146) at a single institute. Correlations between these executive functions and clinical variables were investigated. RESULTS: Significant differences existed in all executive functions among diagnostic groups (CA, F(2,319) = 15.5, P = 3.71 × 10(–7); TE, F(2,319) = 16.2, P = 2.06 × 10(–7); and %PEN, F(2,319) = 21.3, P = 2.15 × 10(–9)). Patients with SCZ had fewer CA and more TE and %PEN than those of HCs (CA, Cohen’s d = −0.70, P = 5.49 × 10(–8); TE, d = 0.70, P = 5.62 × 10(–8); and %PEN, d = 0.82, P = 2.85 × 10(−10)) and FRs (TE, d = 0.46, P = 3.73 × 10(–3) and %PEN, d = 0.38, P = .017). Of the 3 executive functions, CA and %PEN of FRs were intermediately impaired between patients with SCZ and HCs (CA, d = −0.41, P = .011 and %PEN, d = 0.41, P = .012). In contrast, no significant difference in TE existed between FRs and HCs (d = 0.22, P = .18). Although CA and TE were affected by the duration of illness (P < .017), %PEN was not affected by any clinical variable in patients with SCZ (P > .017). CONCLUSIONS: Executive function, particularly %PEN, could be a useful intermediate phenotype for understanding the genetic mechanisms implicated in SCZ pathophysiology.
format Online
Article
Text
id pubmed-7745249
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77452492020-12-22 Differences in Executive Function Among Patients With Schizophrenia, Their Unaffected First-Degree Relatives, and Healthy Participants Kataoka, Yuzuru Shimada, Takamitsu Koide, Yoko Okubo, Hiroaki Uehara, Takashi Shioiri, Toshiki Kawasaki, Yasuhiro Ohi, Kazutaka Int J Neuropsychopharmacol Regular Research Articles BACKGROUND: Patients with schizophrenia (SCZ) display impaired executive functions compared with healthy controls (HCs). Furthermore, unaffected first-degree relatives (FRs) of patients with SCZ independently perform worse executive functions than do HCs. However, few studies have investigated the differences in executive functions assessed among patients with SCZ, FRs, and HCs, and the findings are inconsistent. METHODS: We investigated diagnostic differences in executive functions, namely (1) numbers of categories achieved (CA), (2) total errors (TE), and (3) percentage of perseverative errors of Nelson types (%PEN), using the Wisconsin card sorting test among patients with SCZ (n = 116), unaffected FRs (n = 62), and HCs (n = 146) at a single institute. Correlations between these executive functions and clinical variables were investigated. RESULTS: Significant differences existed in all executive functions among diagnostic groups (CA, F(2,319) = 15.5, P = 3.71 × 10(–7); TE, F(2,319) = 16.2, P = 2.06 × 10(–7); and %PEN, F(2,319) = 21.3, P = 2.15 × 10(–9)). Patients with SCZ had fewer CA and more TE and %PEN than those of HCs (CA, Cohen’s d = −0.70, P = 5.49 × 10(–8); TE, d = 0.70, P = 5.62 × 10(–8); and %PEN, d = 0.82, P = 2.85 × 10(−10)) and FRs (TE, d = 0.46, P = 3.73 × 10(–3) and %PEN, d = 0.38, P = .017). Of the 3 executive functions, CA and %PEN of FRs were intermediately impaired between patients with SCZ and HCs (CA, d = −0.41, P = .011 and %PEN, d = 0.41, P = .012). In contrast, no significant difference in TE existed between FRs and HCs (d = 0.22, P = .18). Although CA and TE were affected by the duration of illness (P < .017), %PEN was not affected by any clinical variable in patients with SCZ (P > .017). CONCLUSIONS: Executive function, particularly %PEN, could be a useful intermediate phenotype for understanding the genetic mechanisms implicated in SCZ pathophysiology. Oxford University Press 2020-07-21 /pmc/articles/PMC7745249/ /pubmed/32692837 http://dx.doi.org/10.1093/ijnp/pyaa052 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of CINP. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Regular Research Articles
Kataoka, Yuzuru
Shimada, Takamitsu
Koide, Yoko
Okubo, Hiroaki
Uehara, Takashi
Shioiri, Toshiki
Kawasaki, Yasuhiro
Ohi, Kazutaka
Differences in Executive Function Among Patients With Schizophrenia, Their Unaffected First-Degree Relatives, and Healthy Participants
title Differences in Executive Function Among Patients With Schizophrenia, Their Unaffected First-Degree Relatives, and Healthy Participants
title_full Differences in Executive Function Among Patients With Schizophrenia, Their Unaffected First-Degree Relatives, and Healthy Participants
title_fullStr Differences in Executive Function Among Patients With Schizophrenia, Their Unaffected First-Degree Relatives, and Healthy Participants
title_full_unstemmed Differences in Executive Function Among Patients With Schizophrenia, Their Unaffected First-Degree Relatives, and Healthy Participants
title_short Differences in Executive Function Among Patients With Schizophrenia, Their Unaffected First-Degree Relatives, and Healthy Participants
title_sort differences in executive function among patients with schizophrenia, their unaffected first-degree relatives, and healthy participants
topic Regular Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745249/
https://www.ncbi.nlm.nih.gov/pubmed/32692837
http://dx.doi.org/10.1093/ijnp/pyaa052
work_keys_str_mv AT kataokayuzuru differencesinexecutivefunctionamongpatientswithschizophreniatheirunaffectedfirstdegreerelativesandhealthyparticipants
AT shimadatakamitsu differencesinexecutivefunctionamongpatientswithschizophreniatheirunaffectedfirstdegreerelativesandhealthyparticipants
AT koideyoko differencesinexecutivefunctionamongpatientswithschizophreniatheirunaffectedfirstdegreerelativesandhealthyparticipants
AT okubohiroaki differencesinexecutivefunctionamongpatientswithschizophreniatheirunaffectedfirstdegreerelativesandhealthyparticipants
AT ueharatakashi differencesinexecutivefunctionamongpatientswithschizophreniatheirunaffectedfirstdegreerelativesandhealthyparticipants
AT shioiritoshiki differencesinexecutivefunctionamongpatientswithschizophreniatheirunaffectedfirstdegreerelativesandhealthyparticipants
AT kawasakiyasuhiro differencesinexecutivefunctionamongpatientswithschizophreniatheirunaffectedfirstdegreerelativesandhealthyparticipants
AT ohikazutaka differencesinexecutivefunctionamongpatientswithschizophreniatheirunaffectedfirstdegreerelativesandhealthyparticipants